recent publications
-
academic article
- Tybl, E., Shi, F. D., Kessler, S. M., Tierling, S., Walter, J., Bohle, R. M., Wieland, S., Zhang, J. Y., Tan, E. M., Kiemer, A. K. Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype Journal of Hepatology 2011 54:994-1001 DOI:10.1016/j.jhep.2010.08.034 PMID:21145819 PMCID:PMC3079004
- Hao, J. W., Campagnolo, D., Liu, R. L., Piao, W. H., Shi, S., Hu, B. Y., Xiang, R., Zhou, Q. H., Vollmer, T., Van Kaer, L., La Cava, A., Shi, F. D. Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation Annals of Neurology 2011 69:721-734 DOI:10.1002/ana.22339 PMID:21425186 PMCID:PMC3082615
- Hao, J. W., Liu, R. L., Piao, W. H., Zhou, Q. H., Vollmer, T. L., Campagnolo, D. I., Xiang, R., La Cava, A., Van Kaer, L., Shi, F. D. Central nervous system (cns)-resident natural killer cells suppress th17 responses and cns autoimmune pathology Journal of Experimental Medicine 2010 207:1907-1921 DOI:10.1084/jem.20092749 PMID:20696699 PMCID:PMC2931174
- Shi, F. D., Zhang, J. Y., Liu, D. R., Rearden, A., Elliot, M., Nachtsheim, D., Daniels, T., Casiano, C. A., Heeb, M. J., Chan, E. K. L., Tan, E. M. Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens Prostate 2005 63:252-258 DOI:10.1002/pros.20181 PMID:15538718
- Megliorino, R., Shi, F. D., Peng, X. X., Wang, X., Chan, E. K. L., Tan, E. M., Zhang, J. Y. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection Cancer Detection and Prevention 2005 29:241-248 DOI:10.1016/j.cdp.2005.03.002 PMID:15896923
- Koziol, J. A., Zhang, J. Y., Casiano, C. A., Peng, X. X., Shi, F. D., Feng, A. C., Chan, E. K. L., Tan, E. M. Recursive partitioning as an approach to selection of immune markers for tumor diagnosis Clinical Cancer Research 2003 9:5120-5126 PMID:14613989
- Tan, E. M., Shi, F. D. Relative paradigms between autoantibodies in lupus and autoantibodies in cancer Clinical and Experimental Immunology 2003 134:169-177 DOI:10.1046/j.1365-2249.2003.02259.x PMID:14616773 PMCID:PMC1808856